GlassScriptPhysician profile
Jane A Singh
NPI 1164886685
$308.19
in general payments reported to CMS, 2019-2025
8 companies · $52.56 in 2025
The $52.56 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.33 · 2020: $53.79 · 2021: $42.85 · 2022: $11.98 · 2023: $120 · 2025: $52.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $172.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $75.11 | 2020-2023 | Farxiga |
| Novo Nordisk INC | $59.65 | 2023-2025 | Ozempic, Wegovy |
| Abbvie INC. | $53.41 | 2021-2023 | Vraylar |
| Lilly USA, LLC | $49.86 | 2020-2021 | |
| Axsome Therapeutics, INC. | $29.63 | 2025 | Auvelity |
| Genentech USA, INC. | $14.83 | 2019 | |
| Mylan Specialty L.P. | $13.20 | 2020 | |
| Nevro Corp. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.